Tech Company Financing Transactions

OncoNano Medicine Funding Round

On 5/18/2018, OncoNano Medicine raised $11.7 million in Series A funding from Salem Partners and private investors.

Transaction Overview

Company Name
Announced On
5/18/2018
Transaction Type
Venture Equity
Amount
$11,700,000
Round
Series A
Investors

Salem Partners (Lead Investor) (John Dyett)

Proceeds Purpose
The funding will be used to support the company's continued clinical development of a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease indications such as cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5323 Harry Hines Blvd.
Dallas, TX 75390
USA
Email Address
Overview
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.
Profile
OncoNano Medicine LinkedIn Company Profile
Social Media
OncoNano Medicine Company Twitter Account
Company News
OncoNano Medicine News
Facebook
OncoNano Medicine on Facebook
YouTube
OncoNano Medicine on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Al Guillem
  Al Guillem LinkedIn Profile  Al Guillem Twitter Account  Al Guillem News  Al Guillem on Facebook
Chief Financial Officer
Matthew Head
  Matthew Head LinkedIn Profile  Matthew Head Twitter Account  Matthew Head News  Matthew Head on Facebook
President
Ravi Srinivasan
  Ravi Srinivasan LinkedIn Profile  Ravi Srinivasan Twitter Account  Ravi Srinivasan News  Ravi Srinivasan on Facebook
VP - Operations
Donald Kruppa
  Donald Kruppa LinkedIn Profile  Donald Kruppa Twitter Account  Donald Kruppa News  Donald Kruppa on Facebook
VP - R & D
Tian Zhao
  Tian Zhao LinkedIn Profile  Tian Zhao Twitter Account  Tian Zhao News  Tian Zhao on Facebook
VP - Regulatory Affairs
Kathy Rath
  Kathy Rath LinkedIn Profile  Kathy Rath Twitter Account  Kathy Rath News  Kathy Rath on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/18/2018: DigitalTown venture capital transaction
Next: 5/18/2018: Decent venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary